{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T21:05:26Z","timestamp":1786223126570,"version":"build-2736575974"},"reference-count":81,"publisher":"Oxford University Press (OUP)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8,1]]},"DOI":"10.1093\/cvr\/cvx112","type":"journal-article","created":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T19:10:54Z","timestamp":1496344254000},"page":"1102-1112","source":"Crossref","is-referenced-by-count":66,"title":["A role for autoantibodies in atherogenesis"],"prefix":"10.1093","volume":"113","author":[{"given":"Rosebella A.","family":"Iseme","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"McEvoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Agnew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick R.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonelle","family":"Handley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Oldmeadow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Attia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,7,27]]},"reference":[{"key":"key\n\t\t\t\t20171012115520_cvx112-B1","author":"World Health Organization"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B2","author":"World Health Organization. Cardiovascular diseases"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B3","doi-asserted-by":"crossref","first-page":"C7","DOI":"10.1016\/j.jacc.2005.09.068","article-title":"Pathogenesis of Atherosclerosis","volume":"47","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B4","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I","article-title":"Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus","volume":"44","year":"2001","journal-title":"Arthr Rheum"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/ncprheum0092","article-title":"Mechanisms of disease: Atherosclerosis in autoimmune diseases","volume":"2","year":"2006","journal-title":"Nat Clin Pract Rheumatol"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B6","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/01.ATV.0000174800.78362.ec","article-title":"Atherosclerosis in patients with autoimmune disorders","volume":"25","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1471-4906(01)01922-6","article-title":"Atherosclerosis an infectious, inflammatory and autoimmune disease","volume":"22","year":"2001","journal-title":"Trends Immunol"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/BF02887674","article-title":"Effect of anti-cardiac myosin antibody on prognosis of patients with acute myocardial infarction","volume":"20","year":"2000","journal-title":"J Tongji Med Univ"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B9","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1196\/annals.1422.049","article-title":"Antiphospholipid antibodies in patients with coronary artery disease: new cardiac risk factors?","volume":"1108","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B10","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1161\/01.ATV.17.11.3159","article-title":"Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction","volume":"17","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B11","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1161\/01.CIR.102.11.1258","article-title":"Anticardiolipin antibodies and recurrent coronary events: a prospective study of 1150 patients","volume":"102","author":"Thrombogenic Factors, and Recurrent Coronary Events Investigators","year":"2000","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B12","first-page":"113","article-title":"Antibodies to cardiolipin in young survivors of myocardial infarction: an association with recurrent cardiovascular events","volume":"1","year":"1986","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B13","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00011-013-0652-x","article-title":"Antiphospholipid antibodies and sub-clinical atherosclerosis in the Coronary Artery Risk Development in Young Adults (CARDIA) cohort","volume":"62","year":"2013","journal-title":"Inflamm Res"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B14","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1161\/01.STR.32.8.1701","article-title":"Beta (2)-Glycoprotein 1-dependent anticardiolipin antibodies and risk of ischemic stroke and myocardial infarction: The Honolulu heart program","volume":"32","year":"2001","journal-title":"Stroke"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B15","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/01.STR.0000117575.48205.2D","article-title":"Anticardiolipin antibodies and risk of ischemic stroke and transient ischemic attack: the Framingham cohort and offspring study","volume":"35","year":"2004","journal-title":"Stroke"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/01.CIR.91.1.23","article-title":"Anti-cardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men","volume":"91","year":"1995","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B17","doi-asserted-by":"crossref","first-page":"1.","DOI":"10.1186\/1471-2261-13-1","article-title":"Low levels of IgM antibodies to oxidized cardiolipin increase and high levels decrease risk of cardiovascular disease among 60-year olds: a prospective study","volume":"13","year":"2013","journal-title":"BMC Cardiovasc Disord"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B18","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1536\/ihj.46.631","article-title":"Association between anticardiolipin antibodies and recurrent cardiac events in patients with acute coronary syndrome","volume":"46","year":"2005","journal-title":"Int Heart J"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B19","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1080\/01616412.1999.11740992","article-title":"Anticardiolipin antibodies are an independent risk factor for ischemic stroke","volume":"21","year":"1999","journal-title":"Neurol Res"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000048623","article-title":"Anticardiolipin antibodies and mortality in patients with ischemic stroke: a prospective follow-up study","volume":"21","year":"2002","journal-title":"Neuroepidemiology"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B21","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s004150170176","article-title":"Recurrent stroke and vascular events in elderly patients with anticardiolipin antibodies: a prospective study","volume":"248","author":"French Study of Aortic Plaques in Stroke Group","year":"2001","journal-title":"J Neurol"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B22","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.atherosclerosis.2005.02.026","article-title":"Antibodies against oxidized LDL and cardiolipin and mortality in patients with coronary heart disease","volume":"183","year":"2005","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B23","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1161\/01.STR.31.6.1289","article-title":"Anticardiolipin antibodies are not an independent risk factor for stroke: an incident case-referent study nested within the MONICA and V\u00e4sterbotten cohort project","volume":"31","year":"2000","journal-title":"Stroke"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.rinim.2012.01.001","article-title":"IgM phosphorylcholine antibodies inhibit cell death and constitute a strong protection marker for atherosclerosis development, particularly in combination with other auto-antibodies against modified LDL","volume":"2","year":"2012","journal-title":"Results Immunol"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B25","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.atherosclerosis.2008.07.009","article-title":"Low levels of IgM antibodies against phosphorylcholine-A potential risk marker for ischemic stroke in men","volume":"203","year":"2009","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B26","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.atherosclerosis.2014.07.030","article-title":"Low levels of IgM antibodies against phosphorylcholine are associated with fast carotid intima media thickness progression and cardiovascular risk in men","volume":"236","author":"IMPROVE Study Group.","year":"2014","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaut.2009.05.003","article-title":"Low levels of IgM antibodies to phosphorylcholine predict cardiovascular disease in 60-year old men: effects on uptake of oxidized LDL in macrophages as a potential mechanism","volume":"34","year":"2010","journal-title":"J Autoimmun"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B28","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ijcard.2012.01.018","article-title":"IgM-phosphorylcholine autoantibodies and outcome in acute coronary syndromes","volume":"167","year":"2013","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B29","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1093\/ndt\/gfp309","article-title":"Low levels of IgM antibodies against phosphorylcholine-A increase mortality risk in patients undergoing haemodialysis","volume":"24","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B30","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1001\/archinte.1994.00420220105012","article-title":"Antibody against oxidized low-density lipoprotein predicting myocardial infarction","volume":"154","year":"1994","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B31","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1161\/STROKEAHA.106.474577","article-title":"Association between IgM against an aldehyde-modified peptide in apolipoprotein B-100 and progression of carotid disease","volume":"38","year":"2007","journal-title":"Stroke"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B32","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1161\/01.STR.30.12.2541","article-title":"Autoantibodies against Oxidatively Modified LDL do not constitute a risk factor for Stroke: A Nested Case-Control Study","volume":"30","year":"1999","journal-title":"Stroke"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B33","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0140-6736(92)90926-T","article-title":"Autoantibody against oxidised LDL and progression of carotid atherosclerosis","volume":"339","year":"1992","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B34","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1194\/jlr.M015776","article-title":"Relationship of IgG and IgM autoantibodies and immune complexes to oxidized LDL with markers of oxidation and inflammation and cardiovascular events: results from the EPIC-Norfolk Study","volume":"52","year":"2011","journal-title":"J Lipid Res"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B35","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1194\/jlr.M600361-JLR200","article-title":"Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events","volume":"48","year":"2007","journal-title":"J Lipid Res"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B36","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/j.jacc.2012.08.979","article-title":"Oxidation-specific biomarkers, prospective 15-year cardiovascular and stroke outcomes, and net reclassification of cardiovascular events","volume":"60","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B37","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.atherosclerosis.2005.12.013","article-title":"Autoantibodies to oxidized LDL and cardiovascular risk: the Framingham Offspring Study","volume":"189","year":"2006","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B38","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ijcard.2012.09.165","article-title":"Antibodies to malondialdehyde oxidized low-density lipoproteins predict long term cardiovascular mortality in high risk patients","volume":"168","year":"2013","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B39","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1161\/STROKEAHA.116.012677","article-title":"Apolipoprotein B-100 Antibody Interaction with Atherosclerotic plaque inflammation and repair processes","volume":"47","year":"2016","journal-title":"Stroke"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B40","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1161\/ATVBAHA.115.306938","article-title":"Low levels of Apolipoprotein B-100 autoantibodies are associated with increased risk of coronary events","volume":"36","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B41","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.atherosclerosis.2013.11.041","article-title":"Plasma autoantibodies against apolipoprotein B-100 peptide 210 in subclinical atherosclerosis","volume":"232","year":"2014","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B42","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1016\/j.atherosclerosis.2006.12.014","article-title":"Autoantibody against the amino acid sequence 661-680 in apo B-100 is associated with decreased carotid stenosis and cardiovascular events","volume":"194","year":"2007","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B43","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.atherosclerosis.2013.02.009","article-title":"Antibodies to citrullinated peptides and risk of coronary heart disease","volume":"228","year":"2013","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B44","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.3899\/jrheum.090188","article-title":"Autoantibodies and the risk of cardiovascular events","volume":"36","year":"2009","journal-title":"J Rheumatol"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B45","article-title":"Rheumatoid factors are associated with subclinical and clinical atherosclerosis in african american women: the Multi-Ethnic Study of Atherosclerosis (MESA)","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B46","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0021-9150(03)00229-6","article-title":"Antibodies to human heat shock protein 60, hypertension and dyslipidemia. A study of joint effects on coronary risk","volume":"169","year":"2003","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B47","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/hq0302.104512","article-title":"Autoimmunity to human heat shock protein 60, Chlamydia pneumoniae infection, and inflammation in predicting coronary risk","volume":"22","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B48","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1161\/01.CIR.0000068338.17948.22","article-title":"Synergistic effect of persistent Chlamydia pneumoniae infection, autoimmunity, and inflammation on coronary risk","volume":"107","year":"2003","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B49","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1161\/01.CIR.100.11.1169","article-title":"Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis: clinical significance determined in a follow-up study","volume":"100","year":"1999","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B50","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/01.CIR.102.8.833","article-title":"Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis","volume":"102","year":"2000","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B51","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1161\/01.CIR.0000038890.39298.8D","article-title":"Relationship of anti-60\u2009kDa heat shock protein and anti-cholesterol antibodies to cardiovascular events","volume":"106","author":"Heart Outcomes Prevention Evaluation (HOPE) Study Investigators.","year":"2002","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B52","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1161\/01.CIR.103.8.1064","article-title":"Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study","volume":"103","year":"2001","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B53","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1136\/hrt.2004.040485","article-title":"Increased titres of anti-human heat shock protein 60 predict an adverse one-year prognosis in patients with acute cardiac chest pain","volume":"91","year":"2005","journal-title":"Heart"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B54","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1002\/art.20622","article-title":"XXIII. Baseline predictors of vascular events","volume":"50","author":"LUMINA Study Group. Systemic lupus erythematosus in a multiethnic US cohort (LUMINA)","year":"2004","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B55","doi-asserted-by":"crossref","first-page":"47.","DOI":"10.1186\/1741-7015-12-47","article-title":"Is atherosclerosis an autoimmune disease?","volume":"12","year":"2014","journal-title":"BMC Med"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B56","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1055\/s-0037-1614566","article-title":"Enhancement of protein S anticoagulant function by b2-glycoprotein I, a major target antigen of antiphospholipid antibodies: b2-glycoprotein I interferes with binding of Protein S to its plasma inhibitor, C4b-binding protein","volume":"81","year":"1999","journal-title":"Thromb Haemost"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B57","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10495-005-0817-3","article-title":"Recruitment of beta-2-glycoprotein 1 to cell surfaces in extrinsic and intrinsic apoptosis","volume":"10","year":"2005","journal-title":"Apoptosis"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B58","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.ejvs.2010.01.028","article-title":"Immunomodulation of vascular diseases: atherosclerosis and autoimmunity","volume":"39","year":"2010","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B59","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s12016-008-8099-5","article-title":"Antiphospholipid antibodies and Atherosclerosis: insights from systemic lupus erythematosus and Primary Antiphospholiid Syndrome","volume":"37","year":"2009","journal-title":"Clinic Rev Allerg Immunol"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B60","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1046\/j.1365-2249.1997.d01-948.x","article-title":"Involvement of beta 2 glycoprotein 1 and anti cardiolipin antibodies in oxidatively modified low density lipoprotein uptake by macrophages","volume":"107","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B61","first-page":"723","article-title":"Atherosclerosis in LDL receptor knockout mice is accelerated by immunization with anti cardiolipin antibodies","volume":"6","year":"1997","journal-title":"Lupus"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B62","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1093\/rheumatology\/ker204","article-title":"Longitudinal levels of apolipoproteins and antibodies against phosphorylcholine are independently associated with carotid artery atherosclerosis 5\u2009years after rheumatoid arthritis onset\u2013a prospective cohort study","volume":"50","year":"2011","journal-title":"Rheumatology"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B63","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.atherosclerosis.2005.11.033","article-title":"Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice","volume":"189","year":"2006","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B64","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jacc.2006.11.054","article-title":"Phosphorylcholine-targeting immunization reduces atherosclerosis","volume":"50","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B65","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2796.2011.02479.x","article-title":"Autoantibodies against apolipoprotein A-1 and phosphorylcholine for diagnosis of non-ST-segment elevation myocardial infarction","volume":"271","year":"2012","journal-title":"J Intern Med"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B66","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1046\/j.1523-1755.2003.00155.x","article-title":"Antiphospholipid antibodies as a risk factor for atherosclerotic events in renal transplant recipients","volume":"64","year":"2003","journal-title":"Kidney Int"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B67","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.clim.2009.04.001","article-title":"Clinical significance of the humoral immune response to modified LDL. Clinical","volume":"134","year":"2010","journal-title":"Clin Immunol"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B68","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1177\/0961203311398884","article-title":"Assessment of IgG antibodies to oxidized LDL in patients with acute coronary syndrome","volume":"20","year":"2011","journal-title":"Lupus"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B69","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1006\/clim.2002.5269","article-title":"Proatherogenic and proinflammatory properties of immune complexes prepared with purified human oxLDL antibodies and human oxLDL","volume":"105","author":"DCCT\/EDIC Research Group","year":"2002","journal-title":"Clin Immunol"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B70","first-page":"571846.","article-title":"Immune response to lipoproteins in Atherosclerosis","volume":"2012","year":"2012","journal-title":"Cholesterol"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B71","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1161\/01.CIR.0000143225.07377.EA","article-title":"Are anti-oxidised low density lipoprotein antibodies pathogenic or protective?","volume":"110","year":"2004","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B72","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1161\/01.CIR.0000143162.56057.B5","article-title":"Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis","volume":"110","year":"2004","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B73","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1080\/08916930500050525","article-title":"Atheroprotective immunization with MDA-modified apo B-100 peptide sequences is associated with activation of Th2 specific antibody expression","volume":"38","year":"2005","journal-title":"Autoimmunity"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B74","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.atherosclerosis.2008.10.017","article-title":"Hypercholesterolemia leads to elevated TGF-\u03b21 activity and T helper 3 dependent autoimmune responses in atherosclerotic mice","volume":"204","year":"2009","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B75","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1161\/01.ATV.0000166518.96137.38","article-title":"Humoral immune response against defined oxidized low-density lipoprotein antigens reflects structure and disease activity of carotid plaques","volume":"25","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B76","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/art.24390","article-title":"Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis","volume":"61","year":"2009","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B77","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1161\/CIRCULATIONAHA.108.781856","article-title":"Elevated heat shock protein 60 levels are associated with higher risk of coronary heart disease in Chinese","volume":"118","year":"2008","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B78","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/jaut.1999.0351","article-title":"Immunization of low-density lipoprotein receptor deficient (LDL-RD) mice with heat shock protein 65 (HSP-65) promotes early atherosclerosis","volume":"14","year":"2000","journal-title":"J Autoimmun"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B79","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1161\/01.ATV.12.7.789","article-title":"Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65","volume":"12","year":"1992","journal-title":"Arterioscler Thromb"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B80","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1196\/annals.1422.062","article-title":"Chronic infections and atherosclerosis","volume":"1108","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"key\n\t\t\t\t20171012115520_cvx112-B81","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/CIRCULATIONAHA.105.547414","article-title":"Anti-heat shock protein 60 autoantibodies induce atherosclerosis in apolipoprotein E-deficient mice via endothelial damage","volume":"112","year":"2005","journal-title":"Circulation"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cardiovascres\/article-pdf\/113\/10\/1102\/19913334\/cvx112.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T22:32:20Z","timestamp":1750285940000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/cardiovascres\/article\/113\/10\/1102\/4055072\/A-role-for-autoantibodies-in-atherogenesis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,27]]},"references-count":81,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,7,27]]},"published-print":{"date-parts":[[2017,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cvr\/cvx112","relation":{},"ISSN":["0008-6363","1755-3245"],"issn-type":[{"value":"0008-6363","type":"print"},{"value":"1755-3245","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,8]]},"published":{"date-parts":[[2017,7,27]]}}}